<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H8333BC44FA464FE0903E0F2A6E567871" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>112th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 3208</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20111014">October 14, 2011</action-date>
			<action-desc><sponsor name-id="S000364">Mr. Shimkus</sponsor> (for
			 himself, <cosponsor name-id="G000550">Mr. Gingrey of Georgia</cosponsor>,
			 <cosponsor name-id="G000558">Mr. Guthrie</cosponsor>,
			 <cosponsor name-id="L000567">Mr. Lance</cosponsor>,
			 <cosponsor name-id="B001243">Mrs. Blackburn</cosponsor>,
			 <cosponsor name-id="R000572">Mr. Rogers of Michigan</cosponsor>,
			 <cosponsor name-id="B000461">Mr. Bilbray</cosponsor>,
			 <cosponsor name-id="B001248">Mr. Burgess</cosponsor>,
			 <cosponsor name-id="B000213">Mr. Barton of Texas</cosponsor>,
			 <cosponsor name-id="P000594">Mr. Paulsen</cosponsor>,
			 <cosponsor name-id="C001075">Mr. Cassidy</cosponsor>, and
			 <cosponsor name-id="L000566">Mr. Latta</cosponsor>) introduced the following
			 bill; which was referred to the <committee-name committee-id="HIF00">Committee
			 on Energy and Commerce</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To reaffirm the Safe Medical Devices Act of 1990 by
		  requiring that the Secretary of Health and Human Services establish a schedule
		  and issue regulations as required under section 515(i) of the Federal Food,
		  Drug, and Cosmetic Act, and for other purposes.</official-title>
	</form>
	<legis-body id="HC5B5714646544EAC84F16C044EFFE863" style="OLC">
		<section id="H74B4A61256184F91975F76AAC15EB169" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Patients Come First Act</short-title>
			 of 2011</quote>.</text>
		</section><section id="HD3839ED6623846ACBDF40443685AC7D3"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress finds as follows:</text>
			<paragraph id="HFD7CE6ACFA7E4C51B0E59312E6E3110D"><enum>(1)</enum><text display-inline="yes-display-inline">Under the Safe Medical Devices Act of 1990
			 (Public Law 101–629), Congress amended section 515 of the Federal Food, Drug,
			 and Cosmetic Act (21 U.S.C. 360e) to require the Food and Drug Administration
			 to reclassify preamendment class III devices to a lower class or to require
			 them to go through the premarket approval process.</text>
			</paragraph><paragraph id="H4F9E2CCFBBE34CE8AA91533F1B2C81E9"><enum>(2)</enum><text>The Food and Drug
			 Administration still has not complied with the mandate of Congress under such
			 Act, jeopardizing the health of the Nation’s patients.</text>
			</paragraph></section><section id="HD6FA36DDE26540FF8075876395812993"><enum>3.</enum><header>Establishment of
			 schedule and promulgation of regulation</header>
			<subsection id="H3B955B134FDA4636A7DED40F83852348"><enum>(a)</enum><header>Establishment of
			 schedule</header><text display-inline="yes-display-inline">Not later than 90
			 days after the date of enactment of this Act, the Secretary of Health and Human
			 Services shall establish the schedule referred to in section 515(i)(3) of the
			 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(i)(3)).</text>
			</subsection><subsection id="H01B7A545F95F4B33BDDA784C26F35E5A"><enum>(b)</enum><header>Regulation</header><text display-inline="yes-display-inline">Not later than one year after the date that
			 the schedule is established under such section 515(i)(3) (as required by
			 <internal-xref idref="H3B955B134FDA4636A7DED40F83852348" legis-path="3.(a)">subsection (a)</internal-xref>) the Secretary shall issue a
			 final regulation under section 515(b) of such Act for each device that the
			 Secretary requires to remain in class III through a determination under section
			 515(i)(2) of such Act.</text>
			</subsection></section><section id="H16DF396DF6F8410991E7A081EBE82EA3"><enum>4.</enum><header>Program to
			 improve the device recall system</header><text display-inline="no-display-inline">Chapter V of the Federal Food, Drug, and
			 Cosmetic Act is amended by inserting after section 518 (21 U.S.C. 360h) the
			 following:</text>
			<quoted-block display-inline="no-display-inline" id="HD4A7E215F43B4A34954E6F40A5B6454E" style="OLC">
				<section id="H1C607F1B84AE4C93A24FC76407698962"><enum>518A.</enum><header>Program to
				improve the device recall system</header>
					<subsection id="H614272ADD3234F01BEBA0D284E0472F7"><enum>(a)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Secretary
				shall—</text>
						<paragraph id="H97DE6AA8E2BA4F2D8867886BD85E2DE7"><enum>(1)</enum><text>establish a
				program to routinely and systematically assess information relating to device
				recalls and use such information to proactively identify strategies for
				mitigating health risks presented by defective or unsafe devices;</text>
						</paragraph><paragraph id="H84138FCFF3714C23AAC722DB9A0F45BB"><enum>(2)</enum><text>clarify procedures
				for conducting device recall audit checks to improve the ability of
				investigators to perform those checks in a consistent manner;</text>
						</paragraph><paragraph id="HF7EA58A1DF4C46D3B533A883C1B40886"><enum>(3)</enum><text>develop detailed
				criteria for assessing whether a person performing a device recall has
				performed an effective correction or action plan for the recall; and</text>
						</paragraph><paragraph id="H07AFB3A727044832943D31E9EF91760C"><enum>(4)</enum><text>document the basis
				for each termination by the Food and Drug Administration of a device
				recall.</text>
						</paragraph></subsection><subsection id="H5BDF535E6F49449CBCBCA34B16AFBAC4"><enum>(b)</enum><header>Assessment
				content</header><text>The program established under subsection (a)(1) shall, at
				a minimum, identify—</text>
						<paragraph id="H2415550B1CC94053BCD2D4EE2021A3E8"><enum>(1)</enum><text>trends in the
				number and types of device recalls;</text>
						</paragraph><paragraph id="H1BA87B0F521B4F1AADE271A2FBCA9AD4"><enum>(2)</enum><text>devices that are
				most frequently the subject of a recall; and</text>
						</paragraph><paragraph id="H2AF78541E15E43BDAE89F0F89FC46101"><enum>(3)</enum><text>underlying causes
				of device
				recalls.</text>
						</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body>
</bill>
